JournalArta
Tuesday, November 17, 2026 · JakartaS&P 7,416.59 ▼1.92%USD/IDR 18,253 ▲0.02%
JournalArta
Global Edition
beyond headlines
Advertisement

UnitedHealth (UNH) Stock Rises 1.12%: Up 3.6% in Five Sessions

Technical analysis of UNH stock on November 16, 2026: price 412.02 USD, trend uptrend, RSI 58.5, support 394.15, resistance 424.98.

By matthew jonathan
November 17, 20264 min read
UnitedHealth (UNH) Stock Rises 1.12%: Up 3.6% in Five Sessions
Logo UnitedHealth Group — JournalArta illustration

Why UNH is in focus today

    Selected automatically from 8 NYSE (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    UnitedHealth Group rose 1.12% to $412.02 on the New York Stock Exchange in Monday’s session, November 16, as the insurer’s shares extended a short-term advance while trading above their 20-day and 50-day averages. The move is constructive, but momentum signals are mixed: rising trading flows support the trend, while the MACD histogram remains negative and the Stochastic oscillator is overbought. The advance puts UNH 3.62% higher over five days and 1.26% higher over one month, according to the supplied market data. The price is above the $407.99 20-day average and $391.73 50-day average, a structure consistent with an uptrend. The 20-day average itself rose 0.55% over five days, indicating that the shorter-term trend is climbing rather than merely holding flat. No new moving-average crossover formed in the latest session.
    Advertisement

    Trend & Price Action

    UNH is at 58% of its 20-session range, between support at $394.15 and resistance at $424.98. That position leaves the shares closer to the upper end of the range, but not yet at the three-month high of $426.55. The distance matters: resistance and the recent high are clustered, creating a meaningful test for the uptrend. A break above that area would indicate buyers are overcoming a nearby supply zone; failure to advance could leave the shares consolidating above their moving averages. The Bollinger bands are narrowing, with a 7.6% width, signaling a squeeze that can precede a larger move but does not determine its direction. UNH’s 63% position within the bands is above the midpoint, consistent with its positive price structure, while the $423.50 upper band sits near the range resistance. The lower band at $392.49 is close to the 20-session support, giving the chart a defined downside area to monitor.
    Price action chart of UNH
    3-month price action chart of UNH: price, SMA20/50, Bollinger, support & resistance.
    Advertisement

    Oscillators & Momentum

    The momentum picture is less decisive than the trend. RSI is neutral at 58.5, suggesting the shares have room before reaching the commonly watched overbought zone, while Stochastic is overbought at %K 85.2 and %D 68.8. Stochastic compares the latest close with the recent trading range; a high reading can reflect strong buying pressure, but it can also warn that a near-term pause is possible. MACD momentum is negative: the MACD is 3.272, below its 3.676 signal line, with a -0.405 histogram. In plain terms, the broader price trend is rising, but the latest momentum reading has not yet confirmed that strength. This divergence argues against treating the recent climb as a one-way move. The RSI’s neutral reading and the absence of a new moving-average crossover also suggest the advance has not produced an unambiguous acceleration signal.
    Momentum chart of UNH
    Momentum chart of UNH: RSI(14), MACD, Stochastic.
    Advertisement

    Volatility & Trading Activity

    The average true range is $10.98, or 2.7% of the share price, indicating moderate daily volatility. That measure estimates typical movement rather than forecasting direction, so even a stable trend can include sizable swings around the averages. Volume was 4,422,800 shares, about 0.9 times the 20-session average of 4,898,965. The session’s rise therefore came on below-normal participation, a caveat when judging the strength of the move. However, OBV—the running balance of volume on up and down sessions—was rising. That increase in OBV supports the advance by showing that buying pressure has been accumulating, even as the latest volume remained below average.
    Advertisement

    Fundamental Context

    According to its SEC filing, UnitedHealth reported quarterly revenue of $112.69 billion for the quarter ended September 30, 2026, down 0.4% from $113.16 billion a year earlier. Net income was $4.11 billion, compared with $2.35 billion in the prior-year quarter, and diluted earnings per share were $4.56. The company also filed a Form 8-K on November 9 reporting a change of directors or officers. These disclosures provide business context, but the verdict below is based on the supplied technical signals.

    Technical Verdict: BUY

    The technical verdict is BUY, supported by the price holding above its 50-day average, the 20-day average remaining above the 50-day, and an uptrend reinforced by rising OBV. The two bullish signals identified in the data are a pullback to the 20-day average within an uptrend and confirmation from OBV; no bearish technical signals were recorded. The key caution is the overbought Stochastic reading alongside negative MACD momentum. The verdict is invalidated if price falls below $391.94. - Ideal Entry Range: $403.77–$412.02 - Exit Target: Target 1 at $442.14; Target 2 at $472.26 - Stop Loss: $391.94 - Validity: Through December 15, 2026 For non-traders, this means the chart favors an advance, but weakening momentum and a defined downside threshold remain important risks.
    Advertisement

    Summary Data UNH

    Last price412.02 USD
    Change 1 day / 5 days / 1 month1.12% / 3.62% / 1.26%
    Trend / MA-crossuptrend / none
    SMA20 / SMA50407.99 / 391.73
    RSI (14) / Stochastic %K58.5 / 85.2
    Bollinger %B / ATR63% / 10.98
    Support / Resistance 20 days394.15 / 424.98
    Data as of17 November 2026 04:00 WIB
    JournalArta research verdict (score)Buy (+84)
    Entry zone403.77 – 412.02
    Target 1 / 2442.14 / 472.26
    Stop loss391.94
    Reward/risk1.5 / 3.0

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    2. 2Women With Autoimmune Diseases Wait About 4 Years for Diagnosis, Study Finds
    3. 3DUP Chairman Lord Morrow Loses Wife and Daughter Within Hours in NI
    4. 4Micron Stock Falls 28% as $35.16 Billion Buyback Nears
    5. 5I’m A Celebrity 2026 Line-Up: Rooney Leads 11 Stars Into Jungle
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Lifestyle · EntertainmentSebastián Lelio Remembered for Films That Reached Beyond the EverydayNov 17
    2. Lifestyle · EntertainmentPrince William and Catherine Play Street Cricket in MumbaiNov 17
    3. World · United StatesMegaspeed Probe Began in 2024, US SaysNov 17
    4. Markets · StocksGE Vernova (GEV) Stock on Monday: Slides 4.93%, Down 15.9% in a MonthNov 17
    5. Advertisement
    6. Business · CompaniesKia Sorento Crosses 4,500 Wholesale Units in IndiaNov 17
    7. Markets · StocksTaiwan Semiconductor (TSM) Stock on Monday: Tumbles 6.34%, Down 11.1% in a MonthNov 17
    8. Markets · StocksEaton (ETN) Stock on Monday: Slides 4.56%, Down 14% in a MonthNov 17
    9. World · EuropeDebenhams Building Faces Court Action Over Break-InsNov 17